OLAYA VARGAS, ALBERTO
MEDICINA Y CIENCIAS DE LA SALUD · Nivel 1
Director en Instituto Nacional de Pediatría
Pediatric oncologist, graduated from the Faculty of Medicine of the National University of Mexico, head of the Transplant program of...
Pediatric oncologist, graduated from the Faculty of Medicine of the National University of Mexico, head of the Transplant program of the National Institute of Pediatrics, master of science, has developed research in the field of pediatric oncology with particular interest in the field of bone marrow transplantation and acute lymphoblastic leukemias in relapse and refractory.
Índice de visibilidad digital v1.0 · Mide qué tan completo está el perfil, no la calidad académica. Escala: 0–39 incompleto · 40–79 intermedio · 80–100 completo. ¿Cómo se calcula? · ¿Te falta un dato? Avísanos
| Nombre | ALBERTO OLAYA VARGAS |
|---|---|
| Área | MEDICINA Y CIENCIAS DE LA SALUD |
| Campo | MEDICINA Y CIENCIAS DE LA SALUD |
| Disciplina | ONCOLOGÍA PEDIÁTRICA |
| Especialidad | INVESTIGACION CLINICA |
| CVU | 96751 |
| Institución | |
|---|---|
| Tipo de institución | Pública |
| Dependencia | DIVISION DE INVESTIGACION MEDICA |
| Entidad | CIUDAD DE MEXICO |
| Nivel | 1 |
| Vigencia | Inicio: 01/01/2025 |
| Fin: 31/12/2029 |
Evolución en el SNII
- Nivel I: 2018–2026
Publicaciones ORCID
- 2026
- Analysis of sociodemographic factors, treatment abandonment, and prognosis of children with acute lymphoblastic leukemia in Mexico Acta Pediátrica de México
- 2025
- Expanding the Horizons of CAR-T Cell Therapy: A Review of Therapeutic Targets Across Diverse Diseases Pharmaceuticals
- 2022
- Hematopoietic stem cell transplantation activity in Mexico during the COVID19 pandemic: on the way to recovery Hematology
- 2021
- Long-term evolution of mucopolysaccharidosis type I in twins treated with enzyme replacement therapy plus hematopoietic stem cells transplantation Heliyon
- Academic Paediatric Surgery and Work-Life Balance: Insights from Mexico Seminars in Pediatric Surgery
- 2020
- Haploidentical Stem Cell Transplantation with CD3+/CD19+ ex-vivo depletion is a therapeutic option in children without a matched donor, or after graft failure: Experience at the National Institute of Pediatrics Hematology & Transfusion International Journal
- 2019
- FANCC Dutch founder mutation in a Mennonite family from Tamaulipas, México Molecular Genetics & Genomic Medicine
- 2018
- IFNG +874 A/T is associated with acute lymphoblastic leukemia in Mexican Mestizos Cytokine
- 2017
- "Exposure to the insecticides permethrin and malathion induces leukemia and lymphoma-associated gene aberrations in vitro". Toxicology in vitro : an international journal published in association with BIBRA
- Hematopoietic stem cell transplantation in 29 patients hemizygous for hypomorphic IKBKG/NEMO mutations. Blood
